Chartwell Investment Partners, LLC Cardiff Oncology, Inc. Transaction History

Chartwell Investment Partners, LLC

  • $2.91 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
BUY
$1.17 - $2.61 $252,151 - $562,491
215,514 Added 266.09%
296,507 $652,000
Q1 2022

Apr 26, 2022
BUY
$2.11 - $7.25 $7,144 - $24,548
3,386 Added 4.36%
80,993 $200,000
Q4 2021

Feb 15, 2022
BUY
$5.18 - $7.24 $402,004 - $561,874
77,607 New
77,607 $466,000

Others Institutions Holding CRDF

# of Institutions
125
Shares Held
25.3M
Call Options Held
866K
Put Options Held
203K
View Full List

About Cardiff Oncology, Inc.

CRDF Quotes by TradingView
  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $175M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email